Axelyf, Inc.
PrivateLast Round
Seed
Aug 19, 2025
Total Funding Raised
$2.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Axelyf, Inc. is a biotechnology company developing RNA therapeutics for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axelyf, Inc. Comparables
Compare Axelyf, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopewell Therapeutics | 88% | |
| NanoVation Therapeutics | 84% | |
| Mana.bio | 82% | |
Axelyf, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 19, 2025 |
Key People
Founding team and executive leadership
Axelyf, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brunnur Ventures | Seed |
| Omega ehf | Seed |
| Silfurberg ehf | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Grew 27% QoQ, from 11 to 14 employees.
- Aug 19, 2025
$2.6M round led by Brunnur Ventures.
Axelyf, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axelyf, Inc.'s valuation, stock price, and market status.